Computational Chemistry at Novartis

Authors: Lewis, Richard; Ertl, Peter; Jacoby, Edgar; Tintelnot-Blomley, Marina; Gedeck, Peter; Wolf, Romain M.; Peitsch, Manuel C.

Source: CHIMIA International Journal for Chemistry, Volume 59, Numbers 7-8, July 2005 , pp. 545-549(5)

Publisher: Swiss Chemical Society

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Computational approaches have become an integral part of modern drug discovery and medicinal chemistry. These approaches can be roughly classified into data/information mining (or filtering) and modelling/simulation methods. Taken together, they represent an ever growing source of hypotheses used to guide experimental approaches and hence drug discovery decisions. Therefore, it is not only important to optimally understand and apply existing methods, but also invest in the development of new algorithms to further improve our selection of drug candidate. The present contribution will describe a few approaches which have become routine at Novartis.

Keywords: COMPUTATIONAL CHEMISTRY; IN SILICO SCREENING; MOLECULAR INFORMATICS; QSAR; STRUCTURE-BASED DRUG DESIGN

Document Type: Research article

DOI: 10.2533/000942905777676155

* This feature is in beta and some links may initially be displayed as numbers instead of article titles. Clicking on any of the links will take you to the recommended articles, regardless of the display of the link.

The full text article is available for purchase

$25.00 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A